Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 9/2013

01-09-2013 | Review

Challenges in the Optimisation of Post-operative Pain Management with Opioids in Obese Patients: a Literature Review

Authors: C. Lloret-Linares, A. Lopes, X. Declèves, A. Serrie, S. Mouly, J.-F. Bergmann, S. Perrot

Published in: Obesity Surgery | Issue 9/2013

Login to get access

Abstract

An increasing number of obese patients are undergoing surgery, particularly bariatric and orthopaedic surgery. The physiological differences between obese and normal-weight subjects may modify not only anaesthetic requirements during surgery but also post-operative analgesic management, raising a number of challenges in a critical period. In this review, we analyse studies of post-operative pain management with opioids in obese subjects. We discuss the genetic factors common to pain and obesity and the factors potentially modifying opioid pharmacokinetics and pharmacodynamics in obese patients, and we analyse the overall efficacy and safety of opioids for pain management during the post-operative period in obese patients. Both modifications to surgical methods and additional analgesic treatments to decrease the requirement for opioids may improve early rehabilitation and quality of care and reduce adverse effects in obese patients.
Literature
1.
Franklin J, Ingvarsson T, Englund M, et al. Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis. Ann Rheum Dis. 2009;68:536–40.PubMedCrossRef
2.
Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14:589–96.PubMed
3.
Schug SA, Raymann A. Postoperative pain management of the obese patient. Best Pract Res Clin Anaesthesiol. 2011;25:73–81.PubMedCrossRef
4.
Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.PubMedCrossRef
5.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef
6.
Nguyen NT, Root J, Zainabadi K, et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg. 2005;140:1198–202. discussion 1203.PubMedCrossRef
7.
Samson AJ, Mercer GE, Campbell DG. Total knee replacement in the morbidly obese: a literature review. ANZ J Surg. 2010;80:595–9.PubMedCrossRef
8.
Schouten JS, van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis. 1992;51:932–7.PubMedCrossRef
9.
Felson DT, Zhang Y, Hannan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum. 1997;40:728–33.PubMedCrossRef
10.
Dougados M, Gueguen A, Nguyen M, et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol. 1992;19:378–84.PubMed
11.
Rajgopal V, Bourne RB, Chesworth BM, et al. The impact of morbid obesity on patient outcomes after total knee arthroplasty. J Arthroplasty. 2008;23:795–800.PubMedCrossRef
12.
Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105 Suppl 1:i16–23.PubMedCrossRef
13.
Ronellenfitsch U, Schwarzbach M, Kring A, et al. The effect of clinical pathways for bariatric surgery on perioperative quality of care. Obes Surg. 2012;22:732–9.PubMedCrossRef
14.
Priano L, Miscio G, Grugni G, et al. On the origin of sensory impairment and altered pain perception in Prader–Willi syndrome: a neurophysiological study. Eur J Pain. 2009;13:829–35.PubMedCrossRef
15.
Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev. 2006;27:710–8.PubMed
16.
Beckers S, Peeters A, Zegers D, et al. Association of the BDNF Val66Met variation with obesity in women. Mol Genet Metab. 2008;95:110–2.PubMedCrossRef
17.
Wu L, Xi B, Zhang M, et al. Associations of six single nucleotide polymorphisms in obesity-related genes with BMI and risk of obesity in Chinese children. Diabetes. 2010;59:3085–9.PubMedCrossRef
18.
Vossen H, Kenis G, Rutten B, et al. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One. 2010;5:e13641.PubMedCrossRef
19.
Lloret Linares C, Hajj A, Poitou C, et al. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population. Obes Surg. 2011;21:1257–64.PubMedCrossRef
20.
Miscio G, Guastamacchia G, Brunani A, et al. Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv Syst. 2005;10:354–8.PubMedCrossRef
21.
Dodet P, Perrot S, Auvergne L, et al. Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a nonobese population. Clin J Pain. 2013;29:43–9.PubMedCrossRef
22.
Stener-Victorin E, Kowalski J, Lundeberg T. A new highly reliable instrument for the assessment of pre- and postoperative gynecological pain. Anesth Analg. 2002;95:151–7. table of contents.PubMedCrossRef
23.
Lundblad H, Kreicbergs A, Jansson KA. Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Joint Surg Br. 2008;90:166–71.PubMed
24.
Nielsen PR, Norgaard L, Rasmussen LS, et al. Prediction of post-operative pain by an electrical pain stimulus. Acta Anaesthesiol Scand. 2007;51:582–6.PubMedCrossRef
25.
Khan F, Ng L, Gonzalez S, Hale T et al. Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy. Cochrane Database Syst Rev 2008:CD004957.
26.
Cheville A, Chen A, Oster G, et al. A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am. 2001;83-A:572–6.PubMed
27.
Nunez M, Lozano L, Nunez E, et al. Total knee replacement and health-related quality of life: factors influencing long-term outcomes. Arthritis Rheum. 2009;61:1062–9.PubMedCrossRef
28.
Vincent HK, Vincent KR, Lee LW, et al. Effect of obesity on inpatient rehabilitation outcomes following total knee arthroplasty. Clin Rehabil. 2007;21:182–90.PubMedCrossRef
29.
Livhits M, Mercado C, Yermilov I, et al. Behavioral factors associated with successful weight loss after gastric bypass. Am Surg. 2010;76:1139–42.PubMed
30.
Chumlea WC, Guo SS, Zeller CM, et al. Total body water reference values and prediction equations for adults. Kidney Int. 2001;59:2250–8.PubMed
31.
Ciangura C, Bouillot JL, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring). 2010;18:760–5.CrossRef
32.
Young JF, Luecke RH, Pearce BA, et al. Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data. J Toxicol Environ Health A. 2009;72:527–40.PubMedCrossRef
33.
Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918.PubMedCrossRef
34.
Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345–50.PubMedCrossRef
35.
Valensi P, Assayag M, Busby M, et al. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord. 1996;20:574–9.PubMed
36.
Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610–5.PubMedCrossRef
37.
Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–822.PubMed
38.
Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–89.PubMedCrossRef
39.
Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121:2126–32.PubMedCrossRef
40.
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121:2111–7.PubMedCrossRef
41.
Lickteig AJ, Slitt AL, Arkan MC, et al. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos. 2007;35:402–9.PubMedCrossRef
42.
Vee ML, Lecureur V, Stieger B, et al. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos. 2009;37:685–93.PubMedCrossRef
43.
More VR, Slitt AL. Alteration of hepatic but not renal transporter expression in diet-induced obese mice. Drug Metab Dispos. 2011;39:992–9.PubMedCrossRef
44.
Buechler C, Weiss TS. Does hepatic steatosis affect drug metabolizing enzymes in the liver? Curr Drug Metab. 2011;12:24–34.PubMedCrossRef
45.
Sugioka N, Haraya K, Fukushima K, et al. Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. Biopharm Drug Dispos. 2009;30:532–41.PubMedCrossRef
46.
Nawa A, Fujita-Hamabe W, Tokuyama S. Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model. Life Sci. 2011;89:834–8.PubMedCrossRef
47.
Cheng Q, Aleksunes LM, Manautou JE, et al. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm. 2008;5:77–91.PubMedCrossRef
48.
Brill MJ, Diepstraten J, van Rongen A, et al. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51:277–304.PubMedCrossRef
49.
Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010;49:71–87.PubMedCrossRef
50.
Lloret Linares C, Decleves X, Oppert JM, et al. Pharmacology of morphine in obese patients: clinical implications. Clin Pharmacokinet. 2009;48:635–51.PubMedCrossRef
51.
Graves DA, Batenhorst RL, Bennett RL, et al. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm. 1983;2:49–53.PubMed
52.
Tateishi T, Krivoruk Y, Ueng YF, et al. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesth Analg. 1996;82:167–72.PubMed
53.
Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics of sufentanil in obese patients. Anesth Analg. 1991;73:790–3.PubMed
54.
Slepchenko G, Simon N, Goubaux B, et al. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology. 2003;98:65–73.PubMedCrossRef
55.
Shibutani K, Inchiosa Jr MA, Sawada K, et al. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth. 2005;95:377–83.PubMedCrossRef
56.
57.
Juvin P, Lavaut E, Dupont H, et al. Difficult tracheal intubation is more common in obese than in lean patients. Anesth Analg. 2003;97:595–600. table of contents.PubMedCrossRef
58.
Ahmad S, Nagle A, McCarthy RJ, et al. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesth Analg. 2008;107:138–43.PubMedCrossRef
59.
El Shobary H, Christou N, Backman SB, et al. Effect of laparoscopic versus open gastric bypass surgery on postoperative pain and bowel function. Obes Surg. 2006;16:437–42.PubMedCrossRef
60.
Rawal N, Sjostrand U, Christoffersson E, et al. Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese: influence on postoperative ambulation and pulmonary function. Anesth Analg. 1984;63:583–92.PubMed
61.
Brodsky JB, Merrell RC. Epidural administration of morphine postoperatively for morbidly obese patients. West J Med. 1984;140:750–3.PubMed
62.
Kyzer S, Ramadan E, Gersch M, et al. Patient-controlled analgesia following vertical gastroplasty: a comparison with intramuscular narcotics. Obes Surg. 1995;5:18–21.PubMedCrossRef
63.
Choi YK, Brolin RE, Wagner BK, et al. Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obes Surg. 2000;10:154–9.PubMedCrossRef
64.
Michaloudis D, Fraidakis O, Petrou A, et al. Continuous spinal anesthesia/analgesia for perioperative management of morbidly obese patients undergoing laparotomy for gastroplastic surgery. Obes Surg. 2000;10:220–9.PubMedCrossRef
65.
Charghi R, Backman S, Christou N, et al. Patient controlled i.v. analgesia is an acceptable pain management strategy in morbidly obese patients undergoing gastric bypass surgery. A retrospective comparison with epidural analgesia. Can J Anaesth. 2003;50:672–8.PubMedCrossRef
66.
Pathiraja C, Silva N, Sharpe G, et al. Is continuous infiltration of local anaesthetic/PCA an acceptable alternate pain management strategy in morbidly obese patients undergoing gastric bypass surgery? A retrospective comparison with epidural analgesia. Sri Lankan Journal of Anaesthesiology. 2010;18:66–71.CrossRef
67.
De Baerdemaeker LE, Jacobs S, Pattyn P, et al. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99:404–11.PubMedCrossRef
68.
Bidgoli J, Delesalle S, De Hert SG, et al. A randomised trial comparing sufentanil versus remifentanil for laparoscopic gastroplasty in the morbidly obese patient. Eur J Anaesthesiol. 2011;28:120–4.PubMedCrossRef
69.
Cottam DR, Fisher B, Atkinson J, et al. A randomized trial of bupivicaine pain pumps to eliminate the need for patient controlled analgesia pumps in primary laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2007;17:595–600.PubMedCrossRef
70.
Kamal H. Ketamine as an adjuvant to morphine for patient controlled analgesia in morbidly obese patients. Journal of Medical Sciences. 2008;8:364–70.CrossRef
71.
Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis. 2009;5:67–71.PubMedCrossRef
72.
Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1:530–5. discussion 535–536.PubMedCrossRef
73.
Kamelgard JI, Kim KA, Atlas G. Combined preemptive and preventive analgesia in morbidly obese patients undergoing open gastric bypass: a pilot study. Surg Obes Relat Dis. 2005;1:12–6.PubMedCrossRef
74.
Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24–8.PubMedCrossRef
75.
Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106:1741–8.PubMedCrossRef
76.
Cabrera Schulmeyer MC, de la Maza J, Ovalle C, et al. Analgesic effects of a single preoperative dose of pregabalin after laparoscopic sleeve gastrectomy. Obes Surg. 2010;20:1678–81.PubMedCrossRef
77.
Strayhorn G. Transcutaneous electrical nerve stimulation and postoperative use of narcotic analgesics. J Natl Med Assoc. 1983;75:811–6.PubMed
78.
Batistich S, Kendall A, Somers S. Analgesic requirements in morbidly obese patients. Anaesthesia. 2004;59:510–1.PubMedCrossRef
79.
Lee WJ, Huang MT, Yu PJ, et al. Laparoscopic vertical banded gastroplasty and laparoscopic gastric bypass: a comparison. Obes Surg. 2004;14:626–34.PubMedCrossRef
80.
Hamza MA, Schneider BE, White PF, et al. Heated and humidified insufflation during laparoscopic gastric bypass surgery: effect on temperature, postoperative pain, and recovery outcomes. J Laparoendosc Adv Surg Tech A. 2005;15:6–12.PubMedCrossRef
81.
Savel RH, Balasubramanya S, Lasheen S, et al. Beneficial effects of humidified, warmed carbon dioxide insufflation during laparoscopic bariatric surgery: a randomized clinical trial. Obes Surg. 2005;15:64–9.PubMedCrossRef
82.
Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2011;21:1407–12.PubMedCrossRef
83.
Steinmiller CL, Diederichs C, Roehrs TA, et al. Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers. J Opioid Manag. 2012;8:227–35.PubMedCrossRef
Metadata
Title
Challenges in the Optimisation of Post-operative Pain Management with Opioids in Obese Patients: a Literature Review
Authors
C. Lloret-Linares
A. Lopes
X. Declèves
A. Serrie
S. Mouly
J.-F. Bergmann
S. Perrot
Publication date
01-09-2013
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2013
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-0998-8

Other articles of this Issue 9/2013

Obesity Surgery 9/2013 Go to the issue

How I Do It

The Safety of Laparoscopic Hand-Sutured Gastrojejunostomy in Gastric Bypass for the Treatment of Morbid Obesity

Original Article

Comparative Review of the Safety and Efficacy of Ferric Carboxymaltose Versus Standard Medical Care for the Treatment of Iron Deficiency Anemia in Bariatric and Gastric Surgery Patients

Clinical Research

Laparoscopic Sleeve Gastrectomy as a Step Approach for Morbidly Obese Patients with Early Stage Malignancies Requiring Rapid Weight Loss for a Final Curative Procedure

Original Contributions

Gastric Bypass Surgery Elevates NT-ProBNP Levels

Letter to the Editor

Letter to the Editor: A Multisite Study of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass

Clinical Research

Sleeve Gastrectomy in the Elderly: A Safe and Effective Procedure with Minimal Morbidity and Mortality